Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Lebwohl

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Archives of Dermatology|February 1, 1991
Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndromeM L Gordon, M G Lebwohl, R G Phelps, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Infectious complications of erythrodermic psoriasisM S Green, J H Prystowsky, S R Cohen, et al.
The British Journal of Dermatology|July 6, 2019
Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: analysis of two randomized controlled trialsS Hsu, L J Green, M G Lebwohl, et al.
Cutis|July 1, 1997
Clobetasol propionate emollient 0.05 percent: hypothalamic-pituitary-adrenal-axis safety and four-week clinical efficacy results in plaque-type psoriasisJ L Jorizzo, K Magee, D M Stewart, et al.
Archives of Pathology & Laboratory Medicine|December 1, 1993
Multiple hamartoma syndrome with osteosarcomaB C Yen, H Kahn, A L Schiller, et al.
Journal of the American Academy of Dermatology|August 14, 1998
Periumbilical pseudoxanthoma elasticum associated with chronic renal failure and angioid streaks--apparent regression with hemodialysisA N Sapadin, M G Lebwohl, S A Teich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2020
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trialR B Warren, J M Carrascosa, E Fumero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label studyM G Lebwohl, L Stein Gold, K Papp, et al.
Journal of Medical Genetics|June 3, 1999
Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTENJ T Celebi, H C Tsou, F F Chen, et al.
The British Journal of Dermatology|October 18, 2018
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trialsR G Langley, A W Armstrong, M G Lebwohl, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Archives of Dermatology|February 1, 1991
Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndromeM L Gordon, M G Lebwohl, R G Phelps, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Infectious complications of erythrodermic psoriasisM S Green, J H Prystowsky, S R Cohen, et al.
The British Journal of Dermatology|July 6, 2019
Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: analysis of two randomized controlled trialsS Hsu, L J Green, M G Lebwohl, et al.
Cutis|July 1, 1997
Clobetasol propionate emollient 0.05 percent: hypothalamic-pituitary-adrenal-axis safety and four-week clinical efficacy results in plaque-type psoriasisJ L Jorizzo, K Magee, D M Stewart, et al.
Archives of Pathology & Laboratory Medicine|December 1, 1993
Multiple hamartoma syndrome with osteosarcomaB C Yen, H Kahn, A L Schiller, et al.
Journal of the American Academy of Dermatology|August 14, 1998
Periumbilical pseudoxanthoma elasticum associated with chronic renal failure and angioid streaks--apparent regression with hemodialysisA N Sapadin, M G Lebwohl, S A Teich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2020
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trialR B Warren, J M Carrascosa, E Fumero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label studyM G Lebwohl, L Stein Gold, K Papp, et al.
Journal of Medical Genetics|June 3, 1999
Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTENJ T Celebi, H C Tsou, F F Chen, et al.
The British Journal of Dermatology|October 18, 2018
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trialsR G Langley, A W Armstrong, M G Lebwohl, et al.
Pageof 4